A practical measurement of thoracic sarcopenia: correlation with clinical parameters and outcomes in advanced lung cancer Source: ERJ Open Res 2016: 00085-2015 Year: 2016
A comparison of existing questionnaires for identifying the causes of interstitial and rare lung diseases Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases Year: 2019
Molecular-pathological correlations in lung cancer Source: International Congress 2016 – PG7 New guidelines for the classification and staging of lung cancer Year: 2016
HRCT in the diagnosis of diffuse lung disease - overlap issues Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar Year: 2010
SW13,15,17 Clinical, radiological and pathological correlations in lung diseases Source: Milan 2017 - Educational material Year: 2017
The associations of interstitial lung abnormalities with cancer diagnoses and mortality Source: Eur Respir J, 56 (6) 1902154; 10.1183/13993003.02154-2019 Year: 2020
How consistently do physicians diagnose and manage drug-induced interstitial lung disease? Two surveys of European ILD specialist physicians Source: ERJ Open Res, 6 (1) 00286-2019; 10.1183/23120541.00286-2019 Year: 2020
An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer Source: Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer Year: 2006
Role of lung biopsies in the diagnosis of interstitial lung diseases in a clinical real-life setting Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021
Associations between comorbidities and survival in patients with interstitial lung diseases Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases Year: 2021
The clinicofunctional features of patients with lung cancer and secondary inflammatory changes Source: Eur Respir J 2006; 28: Suppl. 50, 782s Year: 2006
Clinical management implications of histologic information provided by lung biopsy in the multidisciplinary evaluation of interstitial lung diseases. Source: Virtual Congress 2020 – The hot and cold of interventional pulmonology Year: 2020
Diffuse cystic lung diseases: correlation between radiological and functional status Source: Eur Respir J 2001; 18: Suppl. 33, 210s Year: 2001
Longitudinal cost of care in individuals with different subtypes of interstitial lung diseases Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases Year: 2019
Does surgical lung biopsy help patients with interstitial lung disease? Views of pulmonologists in China Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease Year: 2009
General practitioners and rare lung diseases: a task force for the development of rare lung diseases educational material Source: Guideline 2017 Year: 2016
General practitioners and rare lung diseases: a task force for the development of rare lung diseases educational material Source: Breathe 2016; 12: 341-348 Year: 2016
The relationship between hemoptysis and the features of tumors in primary lung cancer Source: Annual Congress 2007 - Therapy of thoracic malignancies Year: 2007
Why is ILD a different disease in children? Recognising specific diseases in chILDs Source: International Congress 2014 – Interstitial lung disease (ILD) in children Year: 2014
No lung cancer at resection of PET positive lesions: an audit of the lung cancer multidisciplinary team Source: Eur Respir J 2009; 33: 941-942 Year: 2009